<DOC>
	<DOCNO>NCT00011999</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . Combining chemotherapy radiation therapy follow surgery may kill tumor cell . PURPOSE : Phase II trial study effectiveness chemotherapy plus radiation therapy treat patient undergone surgery stage III stage IV head neck cancer .</brief_summary>
	<brief_title>Chemotherapy Radiation Therapy Following Surgery Treating Patients With Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine feasibility adjuvant paclitaxel follow radiotherapy concurrent paclitaxel cisplatin patient undergoing gross complete resection high-risk stage III IV squamous cell carcinoma head neck . - Determine disease-free overall survival patient treat regimen . - Determine acute chronic toxicity regimen patient . - Determine pattern failure patient treat regimen . OUTLINE : Patients receive adjuvant therapy begin 7-14 day gross total surgical resection . Patients receive paclitaxel IV 1 hour day 1 , 8 , 15 . Beginning approximately day 22 , patient undergo radiotherapy daily 5 day week 5.5-6.5 week . Patients also receive paclitaxel IV 1 hour follow cisplatin IV 1-3 hour day 43 , 50 , 57 . Treatment continue absence disease progression unacceptable toxicity . Patients follow every 3 month 2 year , every 6 month 3 year , annually thereafter . PROJECTED ACCRUAL : A total 60 patient accrue study within 11 month .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven stage III IV squamous cell carcinoma oral cavity , oropharynx , larynx , hypopharynx Gross total resection complete planned No le gross total resection No disease require stag surgery Prior gross total resection complete one follow risk factor : Histologically proven multiple lymph node metastasis At least 1 lymph node extracapsular extension tumor Positive margin ( ) resection , include mucosal margin and/or soft tissue deep margin resection OR Gross total resection plan within 14 day study enrollment anticipate need postoperative radiotherapy one following : Multiple clinically/radiologically evident lymph node least 1.5 cm Single clinically/radiologically evident lymph node least 3 cm Histologically proven lymph node metastases No T3 , N0 glottic cancer No nasopharyngeal paranasal sinus carcinoma No distant metastases PATIENT CHARACTERISTICS : Age : 21 Performance status : Zubrod 01 Life expectancy : Not specify Hematopoietic : White blood cell ( WBC ) least 3,000/mm^3 Platelet count least 100,000/mm^3 Hepatic : Bilirubin great 1.5 time upper limit normal ( ULN ) Aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) great 1.5 time ULN Renal : Creatinine great 1.5 ULN Cardiovascular : No unstable angina No myocardial infarction within past 6 month unless successfully treat coronary artery bypass graft percutaneous transluminal coronary angioplasty No uncontrolled arrhythmia No second third degree heart block clinically significant conduction system abnormality unless pacemaker place Pulmonary : No severe chronic obstructive pulmonary disease require 3 hospitalization within past year Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No preexisting grade 2 great peripheral neurotoxicity No prior malignancy within past 3 year except lowrisk nonmelanomatous skin cancer ; carcinoma situ ( e.g. , breast , cervix , bladder ) ; stage T12 , low moderate grade prostate cancer No significant wind infection No fistula No major wound dehiscence Nutritional status adequate PRIOR CONCURRENT THERAPY : Biologic therapy : Concurrent colonystimulating factor neutropenic fever study chemoradiotherapy allow Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics No prior radiotherapy head neck Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
</DOC>